Clinical Trial Detail

NCT ID NCT03480360
Title Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Dartmouth-Hitchcock Medical Center
Indications

Hodgkin's lymphoma

Waldenstroem's macroglobulinemia

multiple myeloma

chronic lymphocytic leukemia

acute lymphoblastic leukemia

myeloproliferative neoplasm

acute myeloid leukemia

myelodysplastic syndrome

non-Hodgkin lymphoma

myelofibrosis

plasma cell neoplasm

chronic myeloid leukemia

Therapies

Cyclophosphamide + Fludarabine

Filgrastim + Mycophenolate mofetil + Tacrolimus

Age Groups: adult senior

No variant requirements are available.